A 3-hit metabolic signaling model for the core symptoms of autism spectrum disorder.

Researchers propose that autism may develop through three steps: having genes that make cells more sensitive to stress, early exposure to environmental triggers, and ongoing stress during brain development (pregnancy to age 3). Since two of these steps can be changed, early detection and treatment might prevent autism or reduce symptoms in some children.

This theoretical review proposes a 3-hit metabolic signaling model for autism spectrum disorder (ASD). The model suggests ASD results from: (1) genetic predisposition affecting mitochondrial function, (2) early environmental triggers activating cellular danger response (CDR), and (3) persistent CDR activation during critical neurodevelopmental periods (late first trimester to 18-36 months). The authors classify these as primers, triggers, and amplifiers respectively. They argue this framework unifies understanding of ASD's diverse features through metabolic signaling pathways.

Using phenylketonuria as an example, they suggest that even genetically-influenced disorders can follow this paradigm while remaining treatable. The model predicts that early identification and intervention targeting modifiable factors could prevent ASD development or significantly reduce core symptoms.

While promising as a theoretical framework, this model requires empirical validation before clinical application. If supported by research, it could guide development of early screening protocols and preventive interventions targeting metabolic pathways during critical developmental periods.

This is a theoretical model without empirical validation. No sample size or experimental data provided. The abstract does not specify what constitutes environmental triggers or detail intervention approaches. Clinical predictions require testing through controlled studies.

A 3-hit metabolic signaling model of the causes of autism spectrum disorder (ASD) is described. The 3-hits required for ASD are: 1) inheritance of a genotype that sensitizes mitochondria and/or eATP-stimulated, intracellular calcium signaling to environmental change, 2) early exposure to environmental triggers that activate the metabolic features of the cell danger response (CDR), and 3) recurrent or persistent exposure to CDR-activating triggers for at least 3-6 months during the critical neurodevelopmental window from the late 1st trimester of pregnancy to the first 18-36 months of life. The three hits associated with an increased risk of ASD can be functionally classified as primers, triggers, and amplifiers of the CDR, respectively. Since the CDR is maintained by metabolic signaling, this new model creates a unified intellectual framework for understanding how the diverse features of ASD are connected.

The example of phenylketonuria (PKU) is given to show that even disorders with very strong genetic predispositions can follow this 3-hit developmental paradigm and still be treatable using the principles of metabolic signaling. Since the 2nd and 3rd hits are modifiable, this model predicts that if the children at greatest risk can be diagnosed and treated before symptoms occur, some of these children may never develop ASD, and if diagnosed after symptoms occur, the core symptoms that are most disabling can be decreased significantly.